Literature DB >> 1975346

Blood pressure and coronary heart disease.

R Collins, R Peto, J Godwin, S MacMahon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1975346     DOI: 10.1016/0140-6736(90)91908-s

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

Review 1.  A practical guide to the management of hypertension in renal transplant recipients.

Authors:  A J Olyaei; A M deMattos; W M Bennett
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

Review 2.  Diabetes and ethnic minorities.

Authors:  J Oldroyd; M Banerjee; A Heald; K Cruickshank
Journal:  Postgrad Med J       Date:  2005-08       Impact factor: 2.401

Review 3.  Irbesartan: an updated review of its use in cardiovascular disorders.

Authors:  A Markham; C M Spencer; B Jarvis
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

Review 4.  Felodipine/metoprolol: a review of the fixed dose controlled release formulation in the management of essential hypertension.

Authors:  M Haria; G L Plosker; A Markham
Journal:  Drugs       Date:  2000-01       Impact factor: 9.546

5.  Stroke seasonality associations with subtype, etiology and laboratory results in the Ludwigshafen Stroke Study (LuSSt).

Authors:  Frederick Palm; Michael Dos Santos; Christian Urbanek; Matthias Greulich; Kathrin Zimmer; Anton Safer; Armin Jürgen Grau; Heiko Becher
Journal:  Eur J Epidemiol       Date:  2013-02-06       Impact factor: 8.082

Review 6.  Thiazide and thiazide-like diuretics: an opportunity to reduce blood pressure in patients with advanced kidney disease.

Authors:  Feras Karadsheh; Matthew R Weir
Journal:  Curr Hypertens Rep       Date:  2012-10       Impact factor: 5.369

Review 7.  Amlodipine. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease.

Authors:  M Haria; A J Wagstaff
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

Review 8.  [Cardiovascular risks under hormone replacement therapy].

Authors:  E Windler
Journal:  Internist (Berl)       Date:  2004-07       Impact factor: 0.743

9.  Endoscopic ulcers are neither meaningful nor validated as a surrogate for clinically significant upper gastrointestinal harm.

Authors:  David Y Graham
Journal:  Clin Gastroenterol Hepatol       Date:  2009-06-25       Impact factor: 11.382

10.  Antihypertensive prescribing practices: impact of the antihypertensive and lipid-lowering treatment to prevent heart attack trial.

Authors:  Marty S Player; James M Gill; Heather Bittner Fagan; Arch G Mainous
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-12       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.